Shareholder Seeks To Halt $1.2B Clinical Data Sale

By Joseph Marks · March 2, 2011, 1:57 PM EST

A Clinical Data Corp. shareholder filed a putative class action Tuesday in Delaware against the drug company's board of directors in an attempt to halt its $1.2 billion acquisition by Forest...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Recent Articles By Joseph

March 31, 2011
Judge Nixes Dismissal Bid In Thalomid Antitrust Suit
March 30, 2011
Sonova Execs Resign Amid Insider Trading Probe
March 29, 2011
FTC OKs $76M Astellas-Maxygen Protein Program Deal
March 28, 2011
Class Rep Pushes To Kill Deal Over Chemo Drug Sales
March 21, 2011
Tenn. Passes Law To Skirt Health Care Mandate
March 18, 2011
US Sues Teva Over Generic HIV Drug
March 14, 2011
Guatemalans Infected With Syphilis Want US To Pay
March 11, 2011
Minn. Pharmacy Class Suit Wrongly Remanded: 8th Circ.
March 09, 2011
Tort Reform Group Sees Conflict In Cuomo Panel
March 09, 2011
State AGs Support Health Care Law At 4th Circ.